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Use of HIV screening/testing and prophylaxis has been found to be low in the general 
emergency department (ED) population. Less is known about the use of HIV/sexually 
transmitted infection (STI) screening, testing, and prophylaxis among sexual assault 
survivors who present to EDs. The main research questions asked whether there was a 
relationship between race, socioeconomic status (SES), geographic region, or age, 
HIV/STI, treatment, and prophylaxis among sexual assault survivors that present to U.S. 
EDs. This study was a secondary analysis of data collected in the NHAMCS years 2010 
to 2016 and included 112 geographic primary sampling units, about 480 hospitals. The 
findings of this quantitative, cross-sectional study, informed using the socioecological 
framework, found that White sexual assault patients had a 3 times greater likelihood of 
receiving an HIV test than Black sexual assault patients. Sexual assault patients in the 
West have an 8.7 times higher lower likelihood of receiving an HIV test than do patients 
in the Northeast, despite having a lower number of sexual assaults. Sexual assault 
patients aged 0 to 10 have an 8 times lower likelihood of receiving appropriate HIV/STI 
medications for treatment or prophylaxis than the reference group. This new knowledge 
can contribute to positive social change through improved care of sexual assault patients, 
a potential decrease in the rate of HIV transmission, and a decrease in social cost and 
stigma. Findings from this research may promote protocols and specialized staff and 
influence policy, research, law, and support of evidence-based interventions to address 
the disparities outlined above.   
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Section 1: Foundation of the Study and Literature Review  
The surveillance and control of HIV and other sexually transmitted infections 
(STIs) is a public health priority in the United States (Centers for Disease Control and 
Prevention [CDC], 2018). Although this has resulted in an 11.7% decrease in HIV 
infections since 2010, there are still opportunities for improvement. In 2015, there were a 
total of 38,500 new cases of HIV estimated in the United States, with a prevalence of 
418.7 per 100,000 and incidence of 7.9% (CDC, 2018). Other STIs are increasing. In 
2015, the prevalence of chlamydia in the United States (among all ages, races, ethnicities, 
and male or female sex) was 475 per 100,000 and increased to 497.3 in 2016 (CDC, 
2018). The rate of gonorrhea in the United States (among all ages, races, ethnicities, and 
male or female sex) also rose from 123 per 100,000 in 2015 to 145.8 per 100,000 in 2016 
(CDC, 2018). The CDC and the United States Department of Health and Human Services 
(2016) recommended that all persons with a nonoccupational exposure who present a 
significant risk of HIV acquisition should be evaluated by a healthcare professional and 
offered nonoccupational postexposure prophylaxis (nPEP). Certain circumstances 
increase the risk of contracting HIV or other STIs (CDC, 2018). One circumstance that 
presents a significant risk of acquiring HIV/STIs is sexual assault (CDC, 2016; 
Draughon, 2012: Ghosh, Rodriquez-Garcia, & Wira, 2013).  
Sexual assault itself is a serious public health problem (CDC, 2018). Definitions 
of rape and sexual assault and how data are collected vary widely. Prevalence statistics 
are thus difficult to interpret and are believed to be underestimates. Breiding et al. (2014), 
using data from the CDC’s National Intimate Partner and Sexual Violence Survey, 
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estimated that there were 323,450 rapes and sexual assaults in 2011 or 1.2 per 100,000. 
The self-survey participants were 18 years and older and had not reported to law 
enforcement.  
The United States Federal Bureau of Investigation (FBI) monitors rapes of all 
ages that have been reported to the police. In 2011, 83,425 forcible rapes of females were 
reported to law enforcement. The rate was 52.7 per 100,000. In December 2011, the FBI 
changed their definition of rape to “penetration, no matter how slight, of the vagina or 
anus with any body part or object, or oral penetration by a sex organ of another person, 
without the consent of the victim.” The reference to females was removed. At present, 
some data are reported according to the legacy definition and some according to the new 
definition. The new definition has resulted in larger numbers. In 2015, rapes reported 
using the legacy definition were 91,261 or 28.4 per 100,000 (FBI, 2015). Rapes 
according to the new definition were 126,134 or 39.3 per 100,000 (FBI, 2015). In 2016, 
there were 130,618 according to the new definition or 40.4 per 100,000 (FBI, 2016).  
The Department of Justice National Crime Victims Survey is a self-report survey that 
collects data on both rape and sexual assault in persons age 12 and older that have not 
been reported to the police. In 2011, The Department of Justice National Crime Victims 
Survey reported 243,800 rapes and sexual assaults or 0.9 per 100,000 (as cited in Truman 
& Planty, 2012). In 2015, there were an estimated 431,840 events or 1.6 per 100,000 
(Truman & Morgan, 2016). In 2016, there were 323,000 incidents or 1.2 per 100,000 
(Morgan & Kena, 2017).    
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Some sexual assault survivors seek care in hospital emergency departments 
(EDs). A search of the WISQARS Nonfatal Injury Reports (2018) revealed that in 2011, 
there were 78,521 victims of injuries (all ages, races, genders) related to sexual assault or 
an age-adjusted rate of 26.3 per 100,000. In 2015, the number had increased to 80,590 or 
26.6 per 100,000 (WISQARS, 2018). In 2016, there were 88,431 or a rate of 29.3 per 
100,000 (WISQARS, 2018).  
In the remainder of Section 1, I state the problem and the purpose of the study. 
The research questions are then listed. Next, I review the theoretical foundation and the 
nature of the study. The literature search strategy and literature review are included. 
Finally, study definitions, assumptions, scope, delimitations, and significance are 
discussed.  
Problem Statement 
Use of HIV screening/testing and prophylaxis has been found to be low in the 
general ED population (Ende, Hein, Sottolano, & Agins, 2008; Merchant & Catanzaro, 
2009; Rothman et al., 2011). In the general population, Blacks had a 70.3% incidence of 
HIV testing in their lifetime of while Whites had only a 39.2% incidence (Lo, Runnels, & 
Cheng, 2018). Less is known about the use of HIV/STI testing and prophylaxis among 
sexual assault survivors who present to EDs. Amey and Bishai (2002) found a link 
between age and underuse; however, this did not completely explain their conclusion that 
many survivors are neither screened nor treated for HIV/STIs. Draughon et al. (2015) 
observed increased compliance where a standardized protocol existed and when the 
perpetrator was other than White race. In another study, researchers found that counseling 
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and prophylaxis were more likely to be received by those younger than 25 years of age, 
single, and employed among other factors, leading the authors to conclude that services 
were not extended to all survivors (Dumont, Van, Kosa, & MacDonald, 2017). Patel, 
Panchal, Piotrowski, and Patel  (2008) and Patel, Roston, Tilmon, Stern, Roston, Patel, 
and Keith (2013)  found that comprehensive medical care management of sexual assault 
was underused. Barriers to screening and treatment that have been identified to include 
personal comfort of physician providers, physician/patient communication, and health 
system obstacles (Amin, Buranosky, & Chang, 2016; Bakhru, Mallinger, & Fox, 2010). 
There are also myriad barriers surrounding medication acceptance and compliance 
(Dejelaj, Patterson, & Romero, 2017). Underuse and barriers may either contribute to or 
be the result of healthcare disparities and inequities related to social determinants.  
Purpose of the Study 
Building on prior research, in this quantitative study, I attempt to identify and 
describe other factors that influence whether sexual assault survivors are offered HIV/STI 
screening/testing and prophylaxis (dependent variables) in hospital EDs when they 
present for treatment. I specifically address the influence of the independent variables of 
race and SES status in adult (≥ 18) sexual assault survivors because this is a meaningful 
gap in the current research.  
If healthcare disparities and inequities related to social determinants are 
identified, they can be addressed and thus inspire positive social change. Among these 
potential changes are improved prevention strategies, improved care of survivors of 
sexual assault as it relates to HIV/STI screening/testing and prophylaxis, a decreased rate 
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of HIV/STI transmission, a decreased economic burden of HIV and sexual assault 
aftercare, and less social stigma. It could also be a step to addressing the challenges of 
researching about sexual assault and increase the knowledge base in the field. 
Individuals, families, the community, and society can benefit, consistent with the 
socioecological theory upon which the study was based.  
Original Research Questions and Hypotheses  
The  original main research questions  were as follows: 
Research Question (RQ)1: Is there a relationship between race (independent 
variable) and HIV/STI testing (dependent variable) among sexual assault survivors?  
Ho1: There is not a significant relationship between race and HIV/STI testing 
among sexual assault survivors. 
HA1: There is a significant relationship between race and HIV/STI testing among 
sexual assault survivors. 
RQ2: Is there a relationship between race (independent variable) and HIV/STI 
prophylaxis (dependent variable) among sexual assault survivors? 
Ho2: There is not a significant relationship between race and HIV/STI prophylaxis 
among sexual assault survivors. 
HA2: There is a significant relationship between race and HIV/STI prophylaxis 
among sexual assault survivors. 
RQ3: Is there a relationship between socioeconomic status (independent variable) 
and HIV/STI testing (dependent variable) among sexual assault survivors?  
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Ho3: There is not a significant relationship between socioeconomic status and 
HIV/STI testing among sexual assault survivors.  
HA3: There is a significant relationship between neighborhood socioeconomic 
status and HIV/STI testing among sexual assault survivors.  
RQ4: Is there a relationship between socioeconomic status (independent variable) 
and HIV/STI prophylaxis received (dependent variable) among sexual assault survivors?  
Ho4: There is not a significant relationship between socioeconomic status and 
HIV/STI prophylaxis received among sexual assault survivors.  
HA4: There is a significant relationship between socioeconomic status and 
HIV/STI among sexual assault survivors.  
Final Research Questions and Hypotheses  
The original research questions as stated above were changed in wording to better 
reflect the answers sought. Seven additional research questions were developed to reflect 
the identification and addition of possible significant variables during the course of the 
research. These changes were necessary to be flexible and make the best use of the 
sample size and characteristics. The lack of availability of some data also contributed to 
the need to alter the research questions and hypotheses slightly. The final research 
questions  were as follows:  
RQ1: Is there a statistically significant difference between races (independent 
variable) and receipt of HIV tests (dependent variable) among sexual assault survivors in 
the ED?  
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H01: There is not a statistically significant difference between race and HIV test 
received among sexual assault survivors in the ED.  
HA1: There is a statistically significant difference between races and HIV test 
received among sexual assault survivors in the ED. 
RQ2: Is there a statistically significant difference between races (independent 
variable) and receipt of urine tests and/or pelvic exams (dependent variables) to diagnose 
sexually transmitted infections among sexual assault survivors in the ED?  
H02: There is not a statistically significant difference between races and receipt of 
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual 
assault survivors in the ED.  
HA2: There is not a statistically significant difference between races and receipt of 
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual 
assault survivors in the ED.  
RQ3: Is there a statistically significant difference between races (independent 
variable) and receipt of HIV/STI medication treatment or prophylaxis (dependent 
variable) among sexual assault survivors in the ED?  
H03: There is not a statistically significant difference between races and receipt of 
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual 
assault survivors in the ED.  
HA3: There is a statistically significant difference between races and receipt of 
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual 
assault survivors in the ED.  
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RQ4: Is there a statistically significant difference between socioeconomic status 
(independent variable) and receipt of HIV tests (dependent variable) among sexual 
assault survivors in the ED?  
H04: There is not a statistically significant difference between socioeconomic 
status and HIV test received among sexual assault survivors in the ED.  
HA4: There is a statistically significant difference between socioeconomic status 
and HIV test received among sexual assault survivors in the ED. 
RQ5: Is there a statistically significant difference between socioeconomic status 
(independent variable) and receipt of urine tests and/or pelvic exams to diagnose sexually 
transmitted infections (dependent variable) among sexual assault survivors in the ED?  
H05: There is not a statistically significant difference between socioeconomic 
status and receipt of urine tests and/or pelvic exams to diagnose sexually transmitted 
infections received among sexual assault survivors in the ED.  
HA5: There is a statistically significant difference between socioeconomic status 
and receipt of urine tests and/or pelvic exams to diagnose sexually transmitted infections 
received among sexual assault survivors in the ED. 
RQ6: Is there a statistically significant difference between socioeconomic status 
(independent variable) and HIV/STI medication treatment or prophylaxis received 
(dependent variable) among sexual assault survivors in the ED?  
H06: There is not a statistically significant difference between socioeconomic 
status and HIV/STI medication treatment or prophylaxis received among sexual assault 
survivors in the ED.  
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HA6: There is a statistically significant difference between socioeconomic status 
and between socioeconomic status and HIV/STI medication treatment or prophylaxis 
received among sexual assault survivors in the ED.  
RQ7: Is there a statistically significant difference between geographic region 
(independent variable) and receipt of HIV tests (dependent variable) among sexual 
assault survivors in the ED?  
H07: There is not a statistically significant difference between geographic region 
and HIV/STI medication treatment or prophylaxis received among sexual assault 
survivors in the ED.  
HA7: There is a statistically significant difference between geographic region and 
between socioeconomic status and HIV/STI medication treatment or prophylaxis 
received among sexual assault survivors in the ED.  
RQ8: Is there a statistically significant difference between geographic region 
(independent variable) and receipt of urinalysis or pelvic exam (dependent variable) 
among sexual assault survivors in the ED?  
H08: There is not a statistically significant difference between geographic region 
and HIV tests received among sexual assault survivors in the ED.  
HA8: There is a statistically significant difference between geographic region and 
urinalysis or pelvic exam received among sexual assault survivors in the ED.  
RQ9: Is there a statistically significant difference between geographic region 
(independent variable) and receipt of appropriate medications (dependent variable) 
among sexual assault survivors in the ED?  
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H09: There is not a statistically significant difference between geographic region 
and appropriate medications received among sexual assault survivors in the ED.  
HA9: There is a statistically significant difference between geographic region and 
appropriate medication received among sexual assault survivors in the ED.  
RQ10: Is there a statistically significant difference between age (independent 
variable) and receipt of urinalysis or pelvic exam (dependent variable) among sexual 
assault survivors in the ED?  
H010: There is not a statistically significant difference between age and urinalysis 
or pelvic exam received among sexual assault survivors in the ED.  
HA10: There is a statistically significant difference between age and urinalysis or 
pelvic exam received among sexual assault survivors in the ED.  
 RQ11: Is there a statistically significant difference between age (independent 
variable) and appropriate medication received (dependent variable) among sexual assault 
survivors in the ED?  
H011: There is not a statistically significant difference between age and 
appropriate medications received among sexual assault survivors in the ED.  
HA11: There is a statistically significant difference between age and appropriate 
medications received among sexual assault survivors in the ED.  
Theoretical Foundation for the Study 
Ecological theories are sets of related concepts that provide a systematic way of 
looking at relationships among variables (Glanz, Rimer, & Viswanath, 2015). Ecological 
models, which are influenced by multiple theories, attempt to explain and predict specific 
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problems in specific settings (Glanz et al., 2015). They are useful for conceptualizing the 
many different levels of influences on health behavior (Glanz et al., 2015). The main 
theory underlying ecologic models is that behavior has multiple levels of influence and 
that all levels of influence are important (Glanz et al., 2015). A second principle is that 
behavior settings restrict the range of a person’s behavior, thus influencing it under 
certain circumstances (Glanz et al., 2015). Further, influences interact across the levels 
(Glanz et al., 2015). Another important principle is that interventions are more powerful 
when they focus on a specific behavior and occur on multiple levels (Glanz et al., 2015).  
The ecologic model was appropriate for this study because I aimed to identify and 
describe the specific problems or behaviors that influence whether sexual assault 
survivors are offered HIV/STI screening/testing and prophylaxis in the specific setting of 
the hospital EDs. The CDC (2018b) uses this model for their violence prevention model. 
There are four levels: individual, relationship, community, and societal (CDC, 2018). 
In this study, the sexual assault survivor or patient is on the individual level. 
Factors to be identified include race and SES status. To be identified are any other factors 
that increase the likelihood that HIV/STI prophylaxis will or will not be offered and/or 
accepted and complied with. On the relationship level are the individual’s family and/or 
support systems and social capitol, which may or may not influence their ability to accept 
and comply with treatment. The health care provider develops a relationship with the 
sexual assault survivor as well; however, their setting of the hospital ED makes it also on 
the community level. Policy changes to intervene on this level may affect the lived 
experience of the sexual assault survivor and the practice of the health care provider. In 
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this study, I touch the societal level by exploring whether social norms about race and 
SES support or hinder care and whether there is inequality among groups.  
Ecologic models have been used in public health for decades. Results of this study 
could result in identification of areas to intervene in the tradition of ecologic models of 
health behavior, health promotion, and multilevel structural change (see Glanz et al., 
2015). A strength of the ecologic model is the study of multilevel influences (Glanz et al., 
2015). Policy or environment changes can help sustain behavior change on the individual 
and community levels (Glanz et al., 2015).  
A weakness of ecologic models is that they can be more demanding to work with 
and difficult to test (Glanz et al., 2015). They can also be costly and impractical when 
interventions are needed on multiple levels (Glanz et al., 2015). Overall, however, 
ecologic models are simple in that they recognize that individuals and communities 
cannot sustain healthy behaviors without policy and environmental support. 
Nature of the Study  
The study was a quantitative cross-sectional survey design using secondary data 
from the National Hospital Ambulatory Medical Care Survey (NHAMCS). The survey 
design enabled me to rapidly make inferences about the population of sexual assault 
survivors. Further, it was pragmatic and economical in form. The key study variables 
were whether the influence of the independent variables of race and SES had a 
relationship to whether adult (≥ 18) sexual assault survivors are offered HIV/STI 




Descriptive statistics were computed using SPSS. Frequencies were run on all 
variables. As part of logistic regression, Chi-square analysis of the measurement 
variables was done to test their significance.  
Literature Search Strategy 
Walden University and Saint Luke’s Health System Libraries were used. 
Databases and search engines used included EBSCO, PubMed, CINAHL, MEDLINE, 
ProQuest, OVID, Open Athens, and Google. Key search terms and combinations of 
search terms included sexual assault, sexual abuse, rape, HIV, STI, gonorrhea, 
chlamydia, forensic nursing, post exposure prophylaxis, nonoccupational post exposure 
prophylaxis, emergency department service use, sexually transmitted disease, emergency 
department, trichomoniasis, and bacterial vaginosis. The scope of literature review was 
primarily the last 16 years.  
Literature Review Related to Key Variables and/or Concepts 
In the following review, I focus on research that addressed the dependent 
variable: HIV/STI screening/testing, treatment, and prophylaxis in sexual assault 
survivors in EDs in the United States. Some were chosen because they used the 
NHAMCS database, which was the source of data for the study. Some were chosen 
because they used similar methodology and/or analytical techniques as the I did. Some 
were chosen as models for the study. In the following paragraphs, I describe in 
chronological order how the problem has been approached thus far and the strengths and 
weaknesses of previous studies. Through review and synthesis of these studies, the 
research question and the selection of the variables in the study are justified.   
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Amey and Bishai (2002) set the precedent for studying the quality of services 
extended to victims of sexual assault. Although their study was limited to women, it 
provided a foundation and rationale for studying the experience of those who present to 
EDs after sexual assault (Amey & Bishai, 2002). The variables of HIV/STI screening and 
treatment, race, and payor status were among those studied and provided a baseline for 
comparison by this study. The study also helps to establish that numbers of patients 
presenting with sexual assault are consistent with those reported to law enforcement, thus 
informing future studies and helping to identify the prevalence. The NHAMCS is the 
database from which Amey and Bishai derived the study sample, as did I in this study. 
The independent variable of race was studied, and the study found that Black women 
received more services. Limitations of the study and using the national database included 
possible coding errors, being limited to information abstracted, difficulty in capturing 
transfer patients, a lower sample size, and the inability to address psychosocial aspects of 
care and follow up (Amey & Bishai, 2002). Overall, Amey and Bishai provided a 
template for this study.   
In 2008, three studies addressed the provision of services to sexual assault 
patients in EDs on the state level. Ende et al. (2008) studied one aspect of care: initiation 
of nPEP. Merchant, Phillips, DeLong, Mayer, and Becker (2008) studied disparities in 
the provision of HIV/STI testing and prophylaxis for women sexually assaulted and 
presenting in Rhode Island EDs. In Illinois, the comprehensive medical care of sexual 
assault victims in EDs including HIV/STI management was studied by Patel, Panchal, 
Piotrowski, and Patel (2008). All concluded that guidelines for care of sexual assault 
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victims were under implemented and services were underprovided to varying degrees. 
Merchant et al. used a logistic regression model for analysis, which I also used in this 
study. These state studies may not be generalizable to other states or the national level.  
Bakhru et al. (2010) also informed, supported, and justified my study by 
identifying potential barriers to postexposure prophylaxis for sexual assault victims in 
EDs, specifically treatments and attitudes of ED physicians. Rothman et al. (2011) also 
informed and supported this study by finding in their national web-based survey that 
most ED programs did not have systematic HIV testing programs for anyone. In 2018, 
Niferatos et al. reinforced these findings by their study of ED patients who received 
HIV/STI laboratory testing, including sexual assault patients. In those cases, a lack of 
documentation of a complete sexual history was identified as a barrier to care and 
associated with suboptimal testing and treatment (Niferatos et al., 2018).  
The hypothesis of increased risk of HIV transmission among sexual assault 
victims (Draughon, 2012) is a central concept underpinning the research problem that 
supported and informed this research project. Draughon and Sheridan (2012) studied part 
of the dependent variable, nPEP evaluation in sexual assault survivors, and found there to 
be a need for further research to better understand the process. Draughon, Anderson, 
Hansen, and Sheridan (2014) reaffirmed that finding in a survey of Sexual Assault Nurse 
Examiner programs and Forensic Nurse Examiners programs studying nPep. These 
justified the need for this study, which builds on and adds to this body of research. In a 
similar study, in 2015, Draughon et al. looked at nurses offering nPEP post sexual 
assault. They also used similar methodology and analysis techniques as I did. Jaureguy, 
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Chariot, Vessieres, and Picard (2016) studied an adult and adolescent sexual assault 
population outside Paris, France. They found that Chlamydia trachomatis was present in 
15% of patients and Neisseria gonorrhea was present in 5% (Jaureguy et al., 2016). Three 
percent of patients had both Chlamydia trachomatis and Neisseria gonorrhea  (Juareguy 
et al., 2016). The only study not affirming that sexual assault was associated with higher 
rates of HIV and STI was done by Van Rooijen, Schim van der Loeff, van Kempen, and 
DeVries (2018). The researchers found that female sexual assault survivors had a positive 
STI rate of 11.2% while nonvictims had a rate of 11.6% (Van Rooijen et al., 2018). 
Survivors did not have  increased odds of getting a STI either (Van Rooijen et al., 2018).  
Very little has been studied in relation to male victims of sexual assault. Du Mont, 
Macdonald, White, and Turner (2013) studied the use of services in male clients in 
Canada and found acceptance, including HIV/STI testing. They identified a need for 
further research, which helped justify my study that addressed both the male and female 
gender. The same year, a study of females receiving comprehensive medical care 
management for sexual assault (which includes HIV/STI screening and treatment) found 
that less than 1/5th of U.S. hospitals complied (Patel et al., 2013). In 2014, Krause et al. 
examined then current practices in EDs, finding that 100% of eligible candidates were 
offered HIV/STI testing in their sample of 138. Malverni, Libois, Gennotte, LaMorté, and 
Mols (2016) determined that only 60% of emergency physicians in their Belgian study 
complied with prescribing guidelines. Of those prescriptions, nearly all were appropriate, 
but compliance with treatment was poor in sexual assault survivors (Malverni et al., 
2016). Tapesana et al. (2017) found that suboptimal care including HIV/STI prophylaxis, 
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testing, and treatment was given to sexual assault patients over a 2-year period. Muriuki, 
Kimani, Machuki, Kiarie, and Roxby (2017), in a Kenyan study that included sexual 
assault survivors of all ages, found PEP given in only 54%, with 34% completing 
treatment. Use of violence services was compared between intimate partners and other 
sexual assault survivors by DuMont, Woldeyoyohannes, Macdonald, Kosa, and Turner 
(2017), including STI prophylaxis and HIV PEP counseling. The authors found that those 
involved in intimate partner violence were less likely to partake in services DuMont et 
al., 2017). DuMont et al. also had a similar focus and methods as this study. DuMont et 
al. (2017) also looked specifically at HIV PEP counseling just in the intimate partner 
violence survivor. Limitations included differences in data collection, self-report bias, 
limited generalizability, and failure to include a multivariate analysis (DuMont et al., 
2017). Monuteaux, Fleegler, and Lee (2017) informed, supported, and justified my study 
as well by helping to establish the scope of the problem and quantify the cost. Monuteaux 
et al., 2017 used the National Hospital Ambulatory Medical Care Survey-ED from 2000 
to 2010, the limitations of which were previously noted. The analysis methods of 
Monuteaux et al. were similar to my study methods and analysis techniques, including 
regression logistics. Scanell, Kim, and Guthrie (2018) looked at the acceptance of HIV 
postexposure prophylaxis in the sexual assault population. As did almost every other 
study, Scanell et al. showed deficiency in health care delivery of nPep in EDs. 
In summary, the above synthesis along with information from other sources 
served as a foundation for further research into the provision of HIV/STI screening, 
treatment, and prophylaxis among sexual assault survivors. The previous studies that 
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used the same dependent variable as I did also provide a foundation and tradition. Many 
of the studies used the same database, methodology, and analytic techniques as me, yet 
new knowledge can be gained by studying this variable in relation to age and SES .  
Study Definitions and Assumptions 
The dependent variable was HIV/STI screening, testing, treatment, or 
prophylaxis. HIV/STI screening is recommended for all victims of sexual assault (CDC, 
2016). Testing may not be desired or efficacious in all circumstances and thus should be 
considered on a case by case basis (CDC, 2016). For example, a sexual assault patient is 
unlikely to test positive for an STI on the same day as the assault. The patient may opt to 
accept treatment without testing based on risk factors. Further, positive results might 
indicate a preexisting STI, which defense attorneys may use to discredit the victim if their 
case is adjudicated (CDC, 2016). Postexposure prophylaxis for HIV requires some testing 
and should also be decided considering risk factors and the patient’s ability to comply 
with the regimen (CDC, 2016).  
The independent variables were race and SES. Race as a biological concept has 
no clear or effective definition for humans, while in practice, race is socially defined. 
Races were defined according to Directive # 15 of the Office of Management and Budget 
Race and Ethnic Standards for Federal Statistics and Administrative Reporting (1977) as 
follows:  
White is a person having origins in any of the original peoples of Europe, North 
Africa, or the Middle East, Black/African American is a person having origins in 
any of the black racial groups of Africa, Asian and Hawaiian/Other Pacific 
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Islander is defined as a person having origins in any of the original peoples of the 
Far East, Southeast Asia, the Indian subcontinent, or the Pacific Islands, 
American Indian or Alaska Native is a person having origins in any of the original 
peoples of North America, and who maintains cultural identification through 
tribal affiliation or community recognition (p. 1).  
Race was coded as follows: 1 = White, 2 = Black/African American, 3 = Asian, 4 
= Native Hawaiian/Other Pacific Islander, 5 = American Indian/Alaska Native, 6 = More 
than one race reported, and -9 = race left blank.  
Socioeconomic status (SES) will be assumed from expected source of payment. 
Private Pay/insurance, Medicare, and Workman’s Compensation will be considered high 
SES. Medicaid, Self-pay, and No Charge will be considered low socioeconomic status. 
Blank, Unknown, and Other were excluded from the final analysis by SPSS. These 
assumptions are necessary because the database does not specifically record income.  
Scope and Delimitations  
As the proposed study is not experimental, threats to internal and external validity 
are confined to selection. Participants will be selected because they have been sexually 
assaulted, and this may predispose them to certain outcomes (Creswell, 2009). For 
example, some people who are sexually assaulted belong to high risk groups (e.g. IV 
drug user) which makes them higher risk for HIV/STIs.  
The proposed study will use data from adults (defined as equal to or greater than 
18 years of age). This is because HIV/STI protocols vary significantly for children and 
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adolescents (CDC, 2016). The study participants will be male and female sex because the 
NHAMCS database collects it that way (NHAMCS, 2015). Persons who present to the  
ED greater than 72 hours after the assault will be excluded because HIV protocols require 
presentation within 72 hours for prophylaxis (CDC, 2016). These measures will help to 
support construct validity. Because the study outcomes are meant to benefit a specific 
population, generalizability is not a primary concern.  
Significance, Summary, and Conclusions 
A potential contribution of the proposed study would be to test the findings of 
Amey and Bishai (2002) that Black/African-American women received more HIV/STI 
services than did white women. The proposed study would also expand and further define 
who is receiving services by including Asian, Native Hawaiian/Other Pacific Islander, 
American Indian/Alaska Native, and more than one race reported. The study also may 
point to opportunities for improvement for service providers, particularly if patient 
acceptance is influenced by provider type and approach. The presence or absence of 
standardized protocols and degree of implementation or compliance may also affect 
patient acceptance. 
The over-arching theme of the literature, and what is well known, is that victims 
of sexual assault are not receiving all the services that they are eligible for in U.S. EDs. If 
any insight can be made into the demographics or behavior of the population or the 
caregivers a potential for positive social change exists consistent with the scope of the 
study. This study would fill gaps in the current literature and extend knowledge in the 
field.   
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 Section 2: Research Design and Data Collection 
In this study, I attempted to identify and describe factors that may have influenced 
whether sexual assault survivors were offered HIV/STI screening/testing and prophylaxis 
(dependent variables) in hospital EDs when they presented for treatment. Independent 
variables of interest were race, socioeconomic status, geographic region, and age. In this 
chapter, I discuss the research design and rationale for the study. I also describe the 
methodology, including population, sampling and sampling procedures, 
operationalization of the variables, and the data analysis  
Research Design and Rationale 
A quantitative approach was appropriate because I used numeric data to 
generalize about the characteristics of sexual assault survivors seen in United States EDs 
from 2010 to 2016 so that inferences could be made about their needs (see Aschengrau & 
Seage, 2014; Creswell, 2009). The cross-sectional design was appropriate because 
secondary data were analyzed. Generalizability, speed, and low cost are advantages of 
secondary data analysis (Aschengrau & Seage, 2014). The data were collected by record 
review. Logistic regression was appropriately used because I was able to place 
individuals into categories, and the dependent variables were binary (yes/no) for HIV/STI 
screening, testing, and prophylaxis.  
Methodology Population 
The original study population was participants in the National Hospital 
Ambulatory Medical Care Surveys 2010 to 2016. The total number of patient records 
reviewed was 159. Cases were identified as sexual assault survivors by, reason for visit 
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codes 58300 (adult sexual abuse) and 58301 (child sexual abuse), and/or diagnosis code 
V71.5 (observation after alleged rape or sexual assault) and/or cause or E code 9601.0 
(rape). Originally, patients under 18 or who presented greater than 72 hours after the 
assault were to be excluded, but they were ultimately included in order to obtain a larger 
sample size. Because the data were secondary data, there were no means to identify 
individuals in the population. It was necessary to arrange the data so that they were easier 
to work with. All data manipulation and statistical analyses were done using SPSS. The 
target population size was expected to be small because of well-known issues with 
reporting and documentation of sexual violence, as previously described. Potential for 
identifying patients exists through cross checking records of patients who receive 
HIV/STI screening/testing and treatment/prophylaxis medications.  
Sampling Procedures  
The Raosoft® sample size calculator was used to determine an a priori adequate 
sample size with a 95% confidence level (CL).  One-hundred fifty-nine records that met 
the identification criteria were identified. A response distribution was estimated at 50% 
because there was no clear expectation of what the results would be. Therefore, 113 
records would have been required for adequate power. All 159 records were ultimately 
included. If other factors had excluded records, the size could have been recalculated or, 
if necessary, a compromise analysis could have been done if an ideal sample size could 
not have been assembled. Surveying a representative random sample was the preferred 
method of data collection for this study because of the ease and rapidity of collection and 
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lower/no cost (see Creswell, 2009). Inclusion criteria was ICD 9 codes 58300, 58301, 
V71.5, or 9601 as noted above.  
NHAMCS (2015) estimates are considered reliable when each is based on 30 
unweighted records and the weighted data had a relative standard of error of less than 
30%. Unweighted records are only used for determining the sample number. Weighted 
data  were used to make national estimates. The secondary data set that I used was the 
NHAMCS.  
The NHAMCS is an annual, national probability sample of ambulatory visits 
made to nonfederal, general, and short-stay hospitals in the U.S. conducted by the 
Centers for Disease Control and Prevention, National Center for Health 
Statistics…. hospitals are inducted into the NHAMCS by field representatives of 
the U.S. Census Bureau. Hospital staff or Census Bureau field representatives 
complete a patient record form for each sampled visit based on information 
obtained from the medical record. (NHAMCS, 2018, p. 1)  
In this analysis, I focused solely on ED visits. NHAMCS is a public access 
database. Permission was not required for the data that were used for this study.   
Operationalization  
There were ultimately four, numeric type independent variables. The independent 
variables were race, socioeconomic status, geographic region, and age. The dependent 
variables were HIV/STI screening, testing, treatment, or prophylaxis. All variables were 
nominal. Numbers are used to classify objects or put them into categories and have no 
quantitative meaning (Polit & Beck, 2010). For example, no services provided was coded 
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as 0, HIV/STI screening provided was coded as 1 and so on. Percentages indicated the 
number of patients receiving services and what services those were.  
Data Analysis Plan 
Sample visit weight was used to analyze data at all stages of the sample design 
(see NHAMCS, 2015). The sampling weights were adjusted for survey nonresponse 
within a set of parameters, which yielded an unbiased national estimate of ED visits, 
percentages, and characteristics (see NHAMCS, 2015). SPSS was used for analysis in 
this study. Missing data were cleaned and controlled for as appropriate. The final 
research questions as noted in Section 1 were:  
RQ1: Is there a statistically significant difference between races (independent 
variable) and receipt of HIV tests (dependent variable) among sexual assault survivors in 
the ED?  
H01: There is not a statistically significant difference between race and HIV test 
received among sexual assault survivors in the ED.  
HA1: There is a statistically significant difference between races and HIV test 
received among sexual assault survivors in the ED. 
RQ2: Is there a statistically significant difference between races (independent 
variable) and receipt of urine tests and/or pelvic exams (dependent variables) to diagnose 
sexually transmitted infections among sexual assault survivors in the ED?  
H02: There is not a statistically significant difference between races and receipt of 
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual 
assault survivors in the ED.  
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HA2: There is not a statistically significant difference between races and receipt of 
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual 
assault survivors in the ED.  
RQ3: Is there a statistically significant difference between races (independent 
variable) and receipt of HIV/STI medication treatment or prophylaxis (dependent 
variable) among sexual assault survivors in the ED?  
H03: There is not a statistically significant difference between races and receipt of 
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual 
assault survivors in the ED.  
HA3: There is a statistically significant difference between races and receipt of 
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual 
assault survivors in the ED.  
RQ4: Is there a statistically significant difference between socioeconomic status 
(independent variable) and receipt of HIV tests (dependent variable) among sexual 
assault survivors in the ED?  
H04: There is not a statistically significant difference between socioeconomic 
status and HIV test received among sexual assault survivors in the ED.  
HA4: There is a statistically significant difference between socioeconomic status 
and HIV test received among sexual assault survivors in the ED. 
RQ5: Is there a statistically significant difference between socioeconomic status 
(independent variable) and receipt of urine tests and/or pelvic exams to diagnose sexually 
transmitted infections (dependent variable) among sexual assault survivors in the ED?  
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H05: There is not a statistically significant difference between socioeconomic 
status and receipt of urine tests and/or pelvic exams to diagnose sexually transmitted 
infections received among sexual assault survivors in the ED.  
HA5: There is a statistically significant difference between socioeconomic status 
and receipt of urine tests and/or pelvic exams to diagnose sexually transmitted infections 
received among sexual assault survivors in the ED. 
RQ6: Is there a statistically significant difference between socioeconomic status 
(independent variable) and HIV/STI medication treatment or prophylaxis received 
(dependent variable) among sexual assault survivors in the ED?  
H06: There is not a statistically significant difference between socioeconomic 
status and HIV/STI medication treatment or prophylaxis received among sexual assault 
survivors in the ED.  
HA6: There is a statistically significant difference between socioeconomic status 
and between socioeconomic status and HIV/STI medication treatment or prophylaxis 
received among sexual assault survivors in the ED.  
RQ7: Is there a statistically significant difference between geographic region 
(independent variable) and receipt of HIV tests (dependent variable) among sexual 
assault survivors in the ED?  
H07: There is not a statistically significant difference between geographic region 
and HIV/STI medication treatment or prophylaxis received among sexual assault 
survivors in the ED.  
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HA7: There is a statistically significant difference between geographic region and 
between socioeconomic status and HIV/STI medication treatment or prophylaxis 
received among sexual assault survivors in the ED.  
RQ8: Is there a statistically significant difference between geographic region 
(independent variable) and receipt of urinalysis or pelvic exam (dependent variable) 
among sexual assault survivors in the ED?  
H08: There is not a statistically significant difference between geographic region 
and HIV tests received among sexual assault survivors in the ED.  
HA8: There is a statistically significant difference between geographic region and 
urinalysis or pelvic exam received among sexual assault survivors in the ED.  
RQ9: Is there a statistically significant difference between geographic region 
(independent variable) and receipt of appropriate medications (dependent variable) 
among sexual assault survivors in the ED?  
H09: There is not a statistically significant difference between geographic region 
and appropriate medications received among sexual assault survivors in the ED.  
HA9: There is a statistically significant difference between geographic region and 
appropriate medication received among sexual assault survivors in the ED.  
RQ10: Is there a statistically significant difference between age (independent 
variable) and receipt of urinalysis or pelvic exam (dependent variable) among sexual 
assault survivors in the ED?  
H010: There is not a statistically significant difference between age and urinalysis 
or pelvic exam received among sexual assault survivors in the ED.  
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HA10: There is a statistically significant difference between age and urinalysis or 
pelvic exam received among sexual assault survivors in the ED.  
 RQ11: Is there a statistically significant difference between age (independent 
variable) and appropriate medication received (dependent variable) among sexual assault 
survivors in the ED?  
H011: There is not a statistically significant difference between age and 
appropriate medications received among sexual assault survivors in the ED.  
HA11: There is a statistically significant difference between age and appropriate 
medications received among sexual assault survivors in the ED.  
Descriptive statistics were completed. Frequencies were run on all variables. Chi-
square was done as part of binomial logistic regression. Binomial logistic regression was 
done to predict outcomes based on characteristics of the population served. A 95% CL  
was desired as stated under sampling.  
Threats to Validity  
The NHAMCS results have sampling and nonsampling errors. Errors included 
reporting and processing errors and nonresponse and incomplete response bias 
(NHAMCS, 2015). In addition, race data  were missing from some records (NHAMCS, 
2015). As stated previously, this study was not experimental; therefore, threats to internal 
and external validity were confined to selection. No threats to construct or statistical 
validity were identified.  
29 
 
Ethical Procedures  
Access to the portion of the NHAMCS being used for this study was open to the 
public for downloading in various formats. Additional data  were available from the 
Research Data Center at the National Center for Health Statistics, which requires an 
approval process for access. NHAMCS falls under Title 42, United States Code, Section 
242K, which allows data collection for health research. All information is only used for 
statistical purposes and is anonymous and confidential (NHAMCS, 2018). Institutional 
review board procedures for this study were followed as required. The IRB approval 
number was  08-28-19-0251965. There were no potential ethical concerns related to 
human participants and no other ethical issues were identified.  
Summary  
In this study, I attempted to identify and describe factors that may have influenced 
whether sexual assault survivors were offered HIV/STI screening/testing and prophylaxis 
in hospital EDs when they presented for treatment. A quantitative approach and cross-
sectional design were appropriate. The original study population was the participants in 
the NHAMCS 2010-2016. Sampling procedures were followed. Variables were identified 
and defined. A data analysis plan was developed and implemented. Threats to validity 
and ethical issues were considered.  
Section 3: Presentation of the Results and Findings 
The purpose of this research was to identify and describe factors that influence 
whether sexual assault survivors were offered HIV/STI screening or testing, and/or 
treatment/prophylaxis (dependent variables) in hospital EDs when they presented for 
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care. Specifically, I looked at the influence of race, socioeconomic status, geographic 
region, and age (independent variables). Data from 2010 through 2016 was used. The 
sample size was 159. The Raosoft® sample size calculator was used to determine that a 
sample size of at least 113 was required for adequate power.  
Sexual assault survivors were identified by reason for visit codes 58300 (adult 
sexual abuse) and 53001 (child sexual abuse) and/or diagnosis code V71.5 (observation 
after alleged rape or sexual assault) and/or cause E code 9601 (rape). Definitions of race 
remained the same; however, only Black and White races were used in the final sample 
because there was not a large enough number of the other races to perform regression. 
Socioeconomic definitions and assumptions were the same.  
Participants were divided into two groups. People with private insurance, 
Medicare, or Workman’s Compensation were assumed to have high income. People with 
Medicaid, self-pay, and no charge were assumed to have low income. Records that had 
methods of payment as other, blank, and unknown were excluded from the 
socioeconomic questions.  
The lack of availability of certain data contributed to the need to alter the research 
questions and hypotheses slightly from the original as noted in Section 1. For example, 
there  were data available for HIV screening/testing specifically, but not for other STIs. I 
assumed that screening/testing for STIs was done if any urine was tested or pelvic exam 
done. I also assumed that treatment/prophylaxis was received by patients who received 
antibiotics, anti-HIV drugs, Plan B emergency contraception, or vaccines that are 
normally part of a sexual assault treatment protocol.  
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The main research questions and hypotheses were:   
RQ1: Is there a statistically significant difference between races (independent 
variable) and receipt of HIV tests (dependent variable) among sexual assault survivors in 
the ED?  
H01: There is not a statistically significant difference between race and HIV test 
received among sexual assault survivors in the ED.  
HA1: There is a statistically significant difference between races and HIV test 
received among sexual assault survivors in the ED. 
RQ2: Is there a statistically significant difference between races (independent 
variable) and receipt of urine tests and/or pelvic exams (dependent variables) to diagnose 
sexually transmitted infections among sexual assault survivors in the ED?  
H02: There is not a statistically significant difference between races and receipt of 
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual 
assault survivors in the ED.  
HA2: There is not a statistically significant difference between races and receipt of 
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual 
assault survivors in the ED.  
RQ3: Is there a statistically significant difference between races (independent 
variable) and receipt of HIV/STI medication treatment or prophylaxis (dependent 
variable) among sexual assault survivors in the ED?  
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H03: There is not a statistically significant difference between races and receipt of 
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual 
assault survivors in the ED.  
HA3: There is a statistically significant difference between races and receipt of 
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual 
assault survivors in the ED.  
RQ4: Is there a statistically significant difference between socioeconomic status 
(independent variable) and receipt of HIV tests (dependent variable) among sexual 
assault survivors in the ED?  
H04: There is not a statistically significant difference between socioeconomic 
status and HIV test received among sexual assault survivors in the ED.  
HA4: There is a statistically significant difference between socioeconomic status 
and HIV test received among sexual assault survivors in the ED. 
RQ5: Is there a statistically significant difference between socioeconomic status 
(independent variable) and receipt of urine tests and/or pelvic exams to diagnose sexually 
transmitted infections (dependent variable) among sexual assault survivors in the ED?  
H05: There is not a statistically significant difference between socioeconomic 
status and receipt of urine tests and/or pelvic exams to diagnose sexually transmitted 
infections received among sexual assault survivors in the ED.  
HA5: There is a statistically significant difference between socioeconomic status 
and receipt of urine tests and/or pelvic exams to diagnose sexually transmitted infections 
received among sexual assault survivors in the ED. 
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RQ6: Is there a statistically significant difference between socioeconomic status 
(independent variable) and HIV/STI medication treatment or prophylaxis received 
(dependent variable) among sexual assault survivors in the ED?  
H06: There is not a statistically significant difference between socioeconomic 
status and HIV/STI medication treatment or prophylaxis received among sexual assault 
survivors in the ED.  
HA6: There is a statistically significant difference between socioeconomic status 
and between socioeconomic status and HIV/STI medication treatment or prophylaxis 
received among sexual assault survivors in the ED.  
RQ7: Is there a statistically significant difference between geographic region 
(independent variable) and receipt of HIV tests (dependent variable) among sexual 
assault survivors in the ED?  
H07: There is not a statistically significant difference between geographic region 
and HIV/STI medication treatment or prophylaxis received among sexual assault 
survivors in the ED.  
HA7: There is a statistically significant difference between geographic region and 
between socioeconomic status and HIV/STI medication treatment or prophylaxis 
received among sexual assault survivors in the ED.  
RQ8: Is there a statistically significant difference between geographic region 
(independent variable) and receipt of urinalysis or pelvic exam (dependent variable) 
among sexual assault survivors in the ED?  
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H08: There is not a statistically significant difference between geographic region 
and HIV tests received among sexual assault survivors in the ED.  
HA8: There is a statistically significant difference between geographic region and 
urinalysis or pelvic exam received among sexual assault survivors in the ED.  
RQ9: Is there a statistically significant difference between geographic region 
(independent variable) and receipt of appropriate medications (dependent variable) 
among sexual assault survivors in the ED?  
H09: There is not a statistically significant difference between geographic region 
and appropriate medications received among sexual assault survivors in the ED.  
HA9: There is a statistically significant difference between geographic region and 
appropriate medication received among sexual assault survivors in the ED.  
RQ10: Is there a statistically significant difference between age (independent 
variable) and receipt of urinalysis or pelvic exam (dependent variable) among sexual 
assault survivors in the ED?  
H010: There is not a statistically significant difference between age and urinalysis 
or pelvic exam received among sexual assault survivors in the ED.  
HA10: There is a statistically significant difference between age and urinalysis or 
pelvic exam received among sexual assault survivors in the ED.  
 RQ11: Is there a statistically significant difference between age (independent 
variable) and appropriate medication received (dependent variable) among sexual assault 
survivors in the ED?  
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H011: There is not a statistically significant difference between age and 
appropriate medications received among sexual assault survivors in the ED.  
HA11: There is a statistically significant difference between age and appropriate 
medications received among sexual assault survivors in the ED.  
In the rest of this section, I outline the time frame for data collection. I also 
describe recruitment and response rates of the secondary data set. Baseline descriptive 
and demographic characteristics of the sample, as well as how representative of the 
population the sample is, are reported. I also report basic statistics and analyses, including 
tables.  
Data Collection of Secondary Data Set 
This study was a secondary analysis of data collected in the NHAMCS years 2010 
to 2016. The annual survey has been conducted since 1992. These data focus on visits to 
hospital EDs. Information is obtained from the patient’s medical record. The sample 
design was composed of multiple stages that include 112 geographic primary sampling 
units, about 480 hospitals within the sampling units, and patient visits to the EDs 
(NHAMCS, 2016). The survey items collected included demographics, reasons for visits, 
cause of injury, diagnosis, diagnostic tests ordered, and medications given or prescribed.  
Table 1 lists the approximate percent of sampled hospitals that participated each 
year and provided complete information and a total unweighted response rate for each of 
the years used in this study.  
Table 1 
Percentage Participation and Unweighted Response Rate 
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2010 12-28-09 to 12-26-10 92% 87.5% 30 
2011 12-27-10 to 12-25-11 87% 80.4% 16 
2012 12-26-11 to 12-28-12 76.3% 63.6% 28 
2013 12-24-12 to 12-22-13 80.8% 65.8% 22 
2014 12-23-13 to 12-21-14 75.5% 60.6% 26 
2015 12-29-14 to 12-27-15 70.8% 55.1% 21 
2016 12-28-15 to 12-25-16 73.4% 51.7% 16 
 
NHAMCS is approved every year by the Ethics Review Board and the 
requirements for informed consent of patients and patient authorization for release of 
medical records are waived (NHAMCS, 2016). Data processing is performed by SRA 
International, Inc., Durham, NC. Error rates usually range between 0.3% and 0.9% 
(NHAMCS, 2016, p.1). NHAMCS data were analyzed using the sampled visit weight 
which were adjusted for survey nonresponse resulting in a nonbiased national estimate of 
ED visit characteristics (NHAMCS, 2016).   
Results and Findings 
In Table 2, the sample age range and mean are reported. Table 2 
Sample Age Range and Mean 
Sample n Range Mean 
159 1-60 23.47 
      




 Full Sample Baseline Descriptive and Demographic Characteristics 
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Baseline characteristic n % 
Sex   
   Female 133 83.6 
   Male 26 16.4 
   Total 159 100% 
Race   
   Blank* 35 22 
   White only 87 54.7 
   Black/ African American only 35 22 
   More than one race reported 2 1.3 
Recoded expected primary source of payment   
   Unknown* 23 14.5 
   Private insurance 38 23.9 
   Medicare 7 4.4 
   Medicaid 61 38.4 
   Worker’s compensation 2 1.3 
   Self-Pay 18 11.3 
   No charge 





Geographic region   
   Northeast 37 17.6 
   Midwest 37 18.9 
   South 57 25.8 
   West 28 13.8 
   
   
 *Excluded from final analysis using SPSS 
In Table 4 the final sample characteristics and numbers are described. Table 4 
Final Sample Racial, Socioeconomic, Geographic Region, and Age Categories 
Baseline characteristic n % 
Race*   
   White only 87 71.3 
   Black/African American only 35 28.7 
   Total 122 100 
Socioeconomic status (SES)**   
   Low SES 79 62 
   High SES 47 38 
   Total 126 100 
Geographic region                                               
  Northeast  37 23.3 
  Midwest  37 23.3 
  South  57 35.8 
  West 28 17.6 
  Total 159 100 
Age groups   
  Group 0-10 23 14.5 
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  Group 11-20  51 32.1 
  Group 21-30 41 25.8 
  Group 31-40 28 17.6 
  Group 41-50 9 5.7 
  Group 51-60 7 4.4 
   Total  159 100 
*There was not a large enough sample of the other races to perform regression. See page 
28. ** Recoded Expected Primary Sources of Payment were divided into high and low 
socioeconomic status for the final analysis and missing data was excluded. See page 28.       
       
A binomial logistic regression was performed to ascertain the effects of race on 
the likelihood that sexual assault patients who present to the Emergency Department will 
receive HIV/STI screening, treatment, or prophylaxis. All variables were nominal so tests 
of linearity were not required. Further, there was no multicollinearity or significant 
outliers. Of the four predictor variables only one was statistically significant: HIV test (as 
shown in Table 5). Whites had 3 times higher likelihood to receive HIV tests than 
Blacks/African Americans. None of the other variables were significant. 
Table 5 
Research Question 1: Binomial Logistic Regression Predicting Likelihood of Receiving 
HIV/STI Screening Based on Race*  
 b SE Wald df p OR 95% CI    
       Lower  Upper 
HIV(1) 
White 
-1.099 .523 4.413 1 .036 .333 .120  .929 
* χ2(4) = 4.320, p < .05. Nagelkerke R2= 5 % Correctly classified 71% of cases. 
Table 6 
Research Question 2: Binomial Logistic Regression Predicting Likelihood of Receiving 
Urinalysis or Pelvic Exam Based on Race* 
 b  SE Wald df p OR 95% CI    
       Lower  Upper 






.140 .564 .062 1 .804 1.151 .381  3.478 
*Urine χ2(4) = 2.542, p < .05. Nagelkerke R2= 3 % Correctly classified 61% of cases. 
 Pelvic χ2(4) = .063, p < .05. Nagelkerke R2= 0 % Correctly classified 84% of cases. 
 
Table 7 
Research Question 3: Binomial Logistic Regression Predicting Likelihood of Receiving 
Appropriate Drug Prophylaxis or Treatment Based on Race* 
 b SE Wald df p OR 95% CI    
       Lower  Upper 
Medication -.358 .402 .795 1 .373 .699 .318  1.536 
* χ2(4) = .796, p < .05. Nagelkerke R2= 0 % Correctly classified 56% of cases. 
A binomial logistic regression was performed to ascertain the effects of 
socioeconomic status on the likelihood that sexual assault patients who present to the 
Emergency Department will receive HIV/STI screening, treatment, or prophylaxis. All 
variables were nominal so tests of linearity were not required. Further, there was no 
multicollinearity or significant outliers. Of the four predictor variables none were 
statistically significant: HIV test (as shown in Table 9). was near significant and might 
have been more so with a larger sample. 
Table 8 
Research Question 4: Binomial Logistic Regression Predicting Likelihood of Receiving 
HIV/STI Screening Based on Socioeconomic Status * 
 b SE Wald df p OR 95% CI   
       Lower  Upper 
HIV(1)  
High SES 
1.489 .784 3.608 1 .057 4.432 .954  20.593 




Research Question 5: Binomial Logistic Regression Predicting Likelihood of Receiving 
Urinalysis or Pelvic Exam Based on Socioeconomic Status*  
 b  SE Wald df p OR 95% CI   
       Lower  Upper 
Urine 
 




-.291 .482 .365 1 .546 .747 .290  1.922 
*Urine χ2(4) = 3.111, p < .05. Nagelkerke R2= 3 % Correctly classified 62% of cases. 
 Pelvic χ2(4) = .063, p < .05. Nagelkerke R2= 3 % Correctly classified 62% of cases. 
 
Table 10 
Research Question 6: Binomial Logistic Regression Predicting Likelihood of Receiving 
Drug Treatment or Prophylaxis Based on Socioeconomic Status  
 b SE Wald df p OR 95% CI   
Medication .101 .370  .075   1 .785    .904 Lower  Upper 
         .438   1.866 
          
 
A binomial logistic regression was performed to ascertain the effects of 
geographic region on the likelihood that sexual assault patients who present to the 
Emergency Department will receive HIV/STI screening, treatment, or prophylaxis. All 
variables were nominal so tests of linearity were not required. Further, there was no 
multicollinearity or significant outliers. The Northeast was used as the reference 
category. Of the four predictor variables only one was statistically significant: HIV test 
(as shown in Table 11). Patients in the West had 8.7 times more likelihood to receive 
HIV tests than patients in the Northeast, despite having 25% less cases. None of the other 




Research Question 7: Binomial Logistic Regression Predicting Likelihood of Receiving 
HIV Test Based on Geographic Region* 
 b SE  Wald df p OR 95% 
CI 
  
        Lower  Upper 
Northeast Reference   5.745 3 .125     
West 2.161 1.088  3.944 1 .047 8.679 1.029  73.215 
South 1.440 1.126  1.634 1 .201 4.219 .464  38.352 
Midwest 1.156 1.106  10.475 1 .296 3.176 .363  27.759 




Research Question 8: Binomial Logistic Regression Predicting Likelihood of Receiving 
Urinalysis Based on Geographic Region* 
 b SE Wald df p OR 95% CI   
       Lower  Upper 
Northeast   1.904 3 .593     
West -.129 .504 .065 1 .788 .879 .328  2.359 
South -.470 .512 .843 1 .359 .625 .229  1.705 
Midwest -.550 .472 1.360 1 .244 .577 .229  1.454 
* χ2(4) = 1.908, p < .05. Nagelkerke R2= 2% Correctly classified 62% of cases. 
 
Table 13 
Research Question 8: Binomial Logistic Regression Predicting Likelihood of Receiving 
Pelvic Exam Based on Geographic Region* 
 b SE Wald df p OR 95% CI   
       Lower  Upper 
Northeast   3.179 3 .365     
West .264 .778 .115 1 .734 1.302 .284  5.977 
South .985 .721 1.866 1 .172 2.679 .652  11.011 
Midwest .154 .732 .044 1 .833 1.167 .278  4.900 
* χ2(4) = 3.049, p < .05. Nagelkerke R2= 3% Correctly classified 85% of cases. 
 
Table 14 
Research Question 9: Binomial Logistic Regression Predicting Likelihood of Receiving 
Appropriate Medications Based on Geographic Region* 
   b SE Wald df p OR 95% CI   
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       Lower  Upper 
Northeast   3.110 3 .375     
West .489 .508 .929 1 .335 1.631 .603  4.414 
South .598 .508 1.382 
 
1 .240 1.818 .671  4.926 
Midwest -.029 .473 .004 1 .951 .971 .384  2.455 
* χ2(4) = 3.140, p < .05. Nagelkerke R2= 3% Correctly classified 57% of cases. 
 
A binomial logistic regression was performed to ascertain the effects of age group 
on the likelihood that sexual assault patients who present to the Emergency Department 
will receive HIV/STI screening, treatment, or prophylaxis. All variables were nominal so 
tests of linearity were not required. Further, there was no multicollinearity or significant 
outliers. Age 11-20 is the reference category. Of the four predictor variables only one was 
statistically significant in any age group: appropriate medications. Age 0-10 was 
statistically significant for 8 times less likelihood of receipt of appropriate medications 
(as shown in Table 18). None of the other variables were significant in any age group. 
Table 15 
 
Research Question 10: Binomial Logistic Regression Predicting Likelihood of Receiving 
HIV Test Based on Age Group 
   b SE Wald df p OR 95% CI   
       Lower  Upper 
Age_New   2.772 4 .597     
Age_New (1) -1.625 1.207 1.813 1 .178 .197 .019  2.096 
Age_New(2) -.074 .738 .010 1 .920 .929 .218  3.947 
Age_New (3) -.508 .799 .404 1 .525 .602 .126  2.880 
Age_New (4) -.654 .885 .546 1 .460 .520 .092  2.948 
* χ2(4) = 3.445, p < .05. Nagelkerke R2= 4 % Correctly classified 87% of cases. 
 
Table 16  
 
Research Question 10: Binomial Logistic Regression Predicting Likelihood of Receiving 
Urinalysis Based on Age Group 
   b SE Wald df p OR 95% CI   
       Lower  Upper 
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Age_New   3.701 4 .448     
Age_New (1) -1.041 .690 2.281 1 .131 .353 .091  1.363 
Age_New (2) -.606 .580 1.094 1 .296 .5454 .175  1.698 
Age_New (3) -.147 .590 .062 1 .804 .864 .272  2.745 
Age_New (4) -.588 .637 .852 1 .356 .556 .159  1.936 
* χ2(4) = 3.808, p < .05. Nagelkerke R2= 3 % Correctly classified 62% of cases. 
 
Table 17 
Research Question 11: Binomial Logistic Regression Predicting 
Likelihood of Receiving Pelvic Exams Based on Age Group 
        
   b SE Wald df p OR 95% CI   
       Lower  Upper 
Age_New    .715 4 .949     
Age_New 
(1) 
.388 .935 .172 1 .678 1.474 .236  9.209 
Age_New 
(2) 





.894 .001 1 .975 .972 .169  5.607 
Age_New 
(4) 
.154 .929 .028 1 .868 1.167 .189  7.207 
* χ2(4) = .727, p < .05. Nagelkerke R2= .008 % Correctly classified 85% of cases. 
 
Table 18 
Research Question 11: Binomial Logistic Regression Predicting Likelihood of Receiving 
Appropriate Medications Based on Age Group 
   b SE Wald df p OR 95% CI   
       Lower  Upper 
Age_New   14.750 4 .005     
Age_New (1) -2.580 1.145 5.074 1 .024 .076 .008  .715 
Age_New (2) .708 .588 1.447 1 .229 2.029 .641  6.425 
Age_New (3) 1.061 .610 3.027 1 .082 2.889 .874  9.544 
Age_New (4) .076 .645 .014 1 .907 1.078 .304  3.820 
* χ2(4) = 28.02, p < .05. Nagelkerke R2= 21 % Correctly classified 65% of cases. 
 
In summary, there is a statistically significant difference between white and black 
races (independent variables) and receipt of HIV tests (dependent variable) among sexual 
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assault survivors in the Emergency Department. There is not a statistically significant 
difference between black and white races and urinalysis, pelvic exams, and appropriate 
medications received among sexual assault survivors in the Emergency Department.  
Further, there is not a statistically significant difference between high and low 
SES  (independent variable) and receipt of HIV tests, urinalysis, pelvic exams, and 
appropriate medications (dependent variables) among sexual assault survivors in the 
Emergency Department. Third, there is a statistically significant difference between 
receipt of HIV tests among patients in the West compared to patients in the Northeast, 
despite there being a greater number of sexual assaults in the Northeast. A patient in the 
West has an 8.7 greater likelihood of receiving an HIV test than patients in the Northeast. 
There were no other statistically significant differences based on geographic region.  
A fourth significant difference found was the receipt of appropriate medications. 
Patients age 0-10 had an 8 times lower likelihood of receiving appropriate medications 
than patients in the reference group. There was not a statistically significant difference 
between age and testing/screening/medications in other age groups.  
In Section 4 the findings will be analyzed and interpreted. Limitations of the study 




 Section 4: Application to Professional Practice and Implications for Social Change  
The purpose of this research was to identify and describe factors that influence 
whether sexual assault survivors were offered HIV/STI screening or testing, and/or 
treatment/prophylaxis when they presented for care in hospital EDs. Only Black and 
White races were used in the final sample where race was a variable because there was 
not a large enough number of other races to perform regression. Subjects were divided 
into two categories also for the purpose of binomial regression. Participants were placed 
in the high socioeconomic status category if they had private insurance, Medicare, or 
Worker’s Compensation insurance. They were categorized as low socioeconomic status if 
they were self-pay, no charge, or had Medicaid. Geographic regions and age groups were 
added to the independent variables because there seemed an opportunity for new 
knowledge.  
I then specifically looked at the influence of these races, socioeconomic statuses, 
geographic regions, and ages on whether patients received HIV tests, urinalyses, pelvic 
exams (females only), and appropriate medications. Medications were deemed 
appropriate if they included drug classes commonly given to sexual assault victims as 
part of protocol, specifically, antibiotics, anti-HIV, emergency contraception (females 
only), or vaccines. That is not to say that other medications given were not appropriate 
for some other aspect of patient care.    
Interpretation of the Findings 
An underlying assumption of this study was that sexual assault is a risk factor for 
acquiring sexually transmitted infections and both are serious public health problems. 
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Further, use of HIV screening/testing and prophylaxis has been found to be low in the 
general ED and the subset sexual assault population (Ende et al., 2008; Merchant & 
Catanzaro, 2009; Rothman et al., 2011). Specifically, Ende et al. (2008) found that 65% 
of sexual assault survivors received screening and prophylaxis in New York State EDs. 
Merchant and Catanzaro (2009) found that 20% of their NHAMCS sample of sexual 
assault patients received HIV testing.  
In the current study, I found that 13.2% of the total sample received HIV 
screening and 12.6 % received prophylaxis. This seems to confirm underuse of HIV 
screening/testing and/or prophylaxis in the ED and among sexual assault patients. 
DuMont et al. (2017) concluded that services were not extended to all sexual assault 
patients. That may be a reason for the small percentages found in the current study. It is 
possible that some procedures or medications were not appropriate based on age or other 
characteristics. Barriers surrounding medication acceptance and compliance (Dejelaj et 
al., 2017) may have also had an impact on this study. Finally, patients may choose not to 
partake of services, which influences results. Amey and Bishai (2012) set a precedent for 
studying the quality of services extended to female victims of sexual assault. Their study 
was the inspiration for the current study. Amey and Bishai (2012) found that Black 
women received more services.  
In the current study, I extended the knowledge base in the discipline by including 
men and did not find a difference in services received between Black and White except 
for HIV testing, which was higher in White individuals. This seems to be a contradiction 
of Amey and Bishai’s (2012) findings and the general findings of Lo et al. (2018) who 
47 
 
observed higher rates of HIV testing in Blacks than in Whites in the general population. 
A further expansion of knowledge was found in the current study by adding SES, region, 
and age as independent variables. Although the other services studied were underused, 
there was not a statistically significant difference in care associated with race or SES. 
Interpretation of Findings by Research Question 
RQ1 addressed whether there was a statistically significant difference between 
races (independent variable) and receipt of HIV tests (dependent variable) among sexual 
assault survivors in the ED. The null hypothesis was rejected because White people had a 
3 times higher likelihood of receiving an HIV test after sexual assaults than did Black 
people. As noted in the previous section, this is a contradiction to previous findings that 
indicated Blacks had a greater likelihood to receive HIV tests in general and after sexual 
assault in particular. 
RQ2 addressed whether there was a statistically significant difference between 
races (independent variable) and receipt of urine tests and/or pelvic exams (dependent 
variables) to diagnose sexually transmitted infections among sexual assault survivors in 
the ED. The null hypothesis was accepted because there were no statistically significant 
relationships found.  
RQ3 addressed whether there was a statistically significant difference between 
races (independent variable) and receipt of HIV/STI medication treatment or prophylaxis 
(dependent variable) among sexual assault survivors in the ED. The null hypothesis was 
true because there was no statistically significant relationship found.  
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RQ4 addressed whether there was a statistically significant difference between 
SES  (independent variable) and receipt of HIV tests (dependent variable) among sexual 
assault survivors in the ED. The null hypothesis was true because there was no 
statistically relationship between variables. This is most likely because the number of 
people receiving HIV tests in the entire sample was only 21, and some patients were 
excluded because there was not enough socioeconomic information.  
RQ5 addressed if there was a statistically significant difference between 
socioeconomic status (independent variable) and receipt of urine tests and/or pelvic 
exams to diagnose sexually transmitted infections (dependent variable) among sexual 
assault survivors in the Emergency Department. The null hypothesis was accepted that 
there was no significant difference.  
The same was true for RQ6 about if there was a statistically significant difference 
between socioeconomic status (independent variable) and HIV/STI medication treatment 
or prophylaxis received (dependent variable) among sexual assault survivors in the ED. 
The answer was no, so the null hypothesis was accepted.  
RQ7 addressed whether there was a statistically significant difference between 
geographic region (independent variable) and receipt of HIV tests (dependent variable) 
among sexual assault survivors in the ED.  The null hypothesis was rejected because 
patients in the West received HIV tests 8.7 times more than the Northeast despite having 
a lower number of sexual assault patients.  
RQ8 addressed whether there was a statistically significant difference between 
geographic region (independent variable) and receipt of urinalysis or pelvic exam 
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(dependent variable) among sexual assault survivors in the ED. The null hypothesis was 
accepted because there was not a statistically significant difference. The null hypothesis 
was also accepted for RQ9, which addressed whether there was a statistically significant 
difference between geographic region (independent variable) and receipt of appropriate 
medications (dependent variable) among sexual assault survivors in the ED.  
RQ10 addressed whether there was a statistically significant difference between 
age (independent variable) and receipt of urinalysis or pelvic exam (dependent variable) 
among sexual assault survivors in the ED. The null hypothesis was true because there 
was no significant relationship.  
RQ11 addressed whether age and receipt of appropriate medications was 
significant among sexual assault survivors in the ED. The null hypothesis was rejected 
because patients between ages 0 and 10 had an 8 times lower likelihood to receive 
appropriate medications than the reference group. This may be because the sample were 
children for whom some medications may not be appropriate or approved.  
Limitations 
Limitations of all studies of sexual assault include difficulty identifying victims. 
This was also a limitation of the current study and resulted in a small sample size and a 
possible threat to validity related to selection of the sample. Participants were identified 
as sexual assault survivors by ICD 9 codes, 58300 adult sexual abuse, 58301 child sexual 
abuse, V71.5 observation after alleged rape or sexual assault, and E code 9601 rape. It is 
possible that some sexual assault patient records were not coded as such, but rather as 
other injuries they may have presented with. Another limitation was that there were not 
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enough nonwhite and nonblack patients to perform regression, and they were excluded 
from the final analysis because the sample size of 122 still had adequate power.  
The assignment of high or low SES assumed that private insurance, Medicare, and 
Worker’s Compensation patients had higher income than self-pay, no charge, and 
Medicare patients. This may impact validity as there may be more effective ways to 
determine SES. The blank, unknown, and other categories were excluded. The sample 
size of 126 still had adequate power. The main threats to reliability are sampling errors 
that occurred in the original database and missing race and/or socioeconomic status data. 
As the current study was specific to sexual assault patients in EDs, it is not generalizable 
to other populations. As this was a cross sectional study, and I studied a given point in 
time, causality cannot be proven. A common use is to identify risk factors, which I did in 
this study.  The study can still be useful when assessing the health needs of populations. 
The study also affords the opportunity to develop hypotheses about cause as long as 
threats of bias are evaluated. Uncertainty regarding the order of causation depends on the 
cause and how it is measured.        
Recommendations 
Recommendations inspired by the current study include further research with 
larger sample sizes. This could help to determine the full extent of services offered to 
sexual assault survivors in the EDs of US hospitals. This study looked at only four of 
many recommended services. Another benefit of a larger sample size would be to include 
more races and the ability to confirm or reject previous findings such as Amey and Bishai 
(2012) and Lo, Runnels, and Cheng (2018).   
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Further, this study only looks at whether the service was given and does not 
reflect if it was offered and refused or inappropriate for some other reason. Knowing 
whether patients accepted or declined services offered would be helpful in determining 
whether there are barriers to acceptance. Knowing whether patients were appropriate for 
services would help determine whether there is a knowledge deficit among care 
providers. These observations could also influence the design and implementation of 
interventions on the socioecological level where they would be most effective. It would 
be interesting to determine whether services are more consistently offered across race, 
socioeconomic, age, and geographic regions in hospitals that use a standardized protocol 
or specially trained staff such as Forensic Nurse Examiners. While conventional wisdom 
seems to support the notion that it does, some previous studies suggest it does not 
(Draughon, Anderson, Hansen, & Sheridan, 2014). The NHAMCS would be a good data 
base to use for that inquiry.  
Implications for Professional Practice and Social Change 
Professional Practice 
Standardizing terms, definitions, and reporting requirements across all law 
enforcement, healthcare, government, and social science disciplines would improve 
further research into the experience of sexual assault survivors. This would improve 
documentation, the ability to collect and compare data during research of all disciplines. 
Criminal justice statistics, medical records, and injury reporting that was comparable on 
local, state, and national levels would enhance the ability to do research within this 
vulnerable population without putting a further burden on them. In NHACMS data, 
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specifically ensuring the correct ICD code for suspected or alleged sexual assault/abuse is 
documented in all cases would help to identify patients for future research. Including 
male victims in all studies of sexual assault will help to collect more data on a segment of 
the population where there is currently little knowledge available.  
It is generally accepted that standardized protocols help to ensure safer care and 
better communication among caregivers. Evidence based protocols and guides are known 
since the 1990’s to improve patient outcomes, promote high quality care, improve 
medicolegal robustness, and reduce costs. They also provide a metric architecture for 
future quality and other assessments.  
Specialized protocols for sexual assault exist as do specially trained forensic nurse 
examiners and other professionals who carry them out. It isn’t known if any of the 
participating hospitals had protocols for the management of sexual assault patients, 
however it behooves one to wonder whether the results of the current study would be 
found if a standard protocol was in place? All hospitals could study their community 
level data to determine whether there are any discrepancies in the way protocols are being 
carried out and why.  
Further, this study can have all caregivers question whether we have preconceived 
notions that affect our judgement when using optional risk-based guidelines over routine 
screening for HIV. How do our posture, attitude, and presentation of facts when offering 
HIV screening and/or prophylaxis convey our feelings about race, socioeconomic status, 
sexual assault, and/or the acceptance of HIV screening/prophylaxis? Do these things 
influence whether a patient accepts?  
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Positive Social Change 
A positive social change that could occur as the result of this study would be 
improved care of survivors of sexual assault as it relates to HIV/STI screening/testing and 
prophylaxis. A caregiver who is aware that discrepancies in services can occur may 
incorporate offering HIV screening on the individual level into their patient routine. That 
caregiver can also promote the use of standardized protocols and specialized staff in the 
hospital community level. This could eventually result in decreased rate of HIV 
transmission in the community. That in turn could decrease the cost of HIV and sexual 
assault aftercare on the community and societal level.  
Another positive social change that could occur as a result of the application of 
this study is less social stigma for sexual assault victims. A standardized protocol that 
makes HIV screening a routine does not single out any one person or group or make 
value judgements. Early identification is often hindered by stigma, but a protocol reduces 
the risk, by letting patients know it is a part of comprehensive health care.  
Finally, contributing to the knowledge base about sexual assault victims 
contributes to positive social change. Increased awareness of the challenges of sexual 
assault victims that filters up to the policy making level can help to influence the priority 
given to research funds, the enactment and enforcement of laws, and the support of 
evidence-based interventions.  
Conclusion 
This study has provided important information about the care and services 
provided to sexual assault patients in United States EDs. Specifically, a white patient has 
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a 3 times greater likelihood of receiving HIV testing than a black person. Patients in the 
Northeast have an 8.7 times lower likelihood to receive an HIV test than patients in other 
geographic regions, despite a greater number of sexual assault patients. Patients in the 
age group of 0-10 have an 8 times lower likelihood of receiving appropriate medications 
than the reference category. This is important new information that contributes to and 
fills gaps in the knowledge base for the care of sexual assault victims in US Hospital EDs 
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